Halozyme Therapeutics shares owned by Sonora Investment Management Group
Quarter-by-quarter ownership of Halozyme Therapeutics shares owned by Sonora Investment Management Group
from 13F filings
Historical chart of Sonora Investment Management Group investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Sonora Investment Management Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Sonora Investment Management Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $4.4M | 3.8M | 1.16 |
| 2025-06-30 | $4.0M | 4.0M | 1.00 |
| 2025-03-31 | $4.2M | 4.0M | 1.05 |
| 2024-12-31 | $3.9M | 4.1M | 0.95 |
| 2024-09-30 | $4.1M | 4.1M | 1.00 |
| 2024-06-30 | $3.7M | 4.2M | 0.88 |
| 2024-03-31 | $3.7M | 4.2M | 0.88 |
| 2023-09-30 | $3.7M | 4.4M | 0.84 |
| 2023-06-30 | $3.1M | 3.6M | 0.84 |
| 2023-03-31 | $1.7M | 2.0M | 0.85 |
More positions owned by Sonora Investment Management Group
View all positions for Sonora Investment Management Group